Search
+
    SEARCHED FOR:

    CANCER MEDICINES

    Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant

    Biocon Biologics received EMA approval to manufacture biosimilar Bevacizumab in Bengaluru, providing additional capacity to address patients' needs in Europe for treating cancer. The Bengaluru facility was also approved for biosimilar Trastuzumab manufacturing. EMA renewed GMP certificates for Biocon's facilities in Bengaluru and Malaysia. USFDA issued four observations after inspecting Biocon's Andhra Pradesh plant, concluding inspections on June 21, 2024.

    Govt allows global tenders to access 120 key, patented drugs

    In what could ease access to some patented medicines, the government has allowed global tenders to be floated for procurement of 120 drugs, including anti-diabetic medication Semaglutide, after the health ministry raised concerns over lack of domestic options.

    Tattoos can increase risk of lymphoma - new study

    ​Tattoos are now a mainstream means to express identity or celebrate milestones in life. Yet we know very little about the long-term health effects. Hazardous chemicals in tattoo ink have received attention in Europe during the last ten years. In parallel, research has shown that the ink that is injected into the skin does not stay there.

    Study finds Mediterranean diet is linked to lower mortality risk in women

    A recent study suggests that women adhering to the Mediterranean diet have a 23% lower risk of premature death. This largely plant-based diet, rich in nuts, fruits, vegetables, and olive oil, reduces cholesterol, obesity, and insulin resistance, lowering the risk of metabolic disorders like diabetes and heart disease. The research, published in The Journal of the American Medical Association, followed over 25,000 US women for up to 25 years, highlighting the diet's potential in promoting longevity and reducing mortality, including cancer-related deaths.

    Pfizer drug extends life for people with rare form of lung cancer

    A Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival outcomes for people in the advanced stages of a rare form of the disease, according to trial results published Friday.

    Exercise & diet play key role in enhancing survival for cancer patients

    ​The mainstays of cancer treatment remain surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy and hormone therapy. But there are other treatments and strategies - "adjunct" or supportive cancer care - that can have a powerful impact on a patient's quality of life, survival and experience during cancer treatment.

    The Economic Times
    BACK TO TOP